factor viii + von Willebrand factor

Factor VIII + von Willebrand Factor is a combination biologic therapy used to treat and prevent bleeding episodes in patients with hemophilia A or von Willebrand disease (VWD). Both components are naturally occurring proteins essential for normal blood clotting. Factor VIII is a glycoprotein involved in the intrinsic pathway of the coagulation cascade; it circulates bound to von Willebrand Factor (vWF), which stabilizes it and prevents rapid degradation. vWF also mediates platelet adhesion at sites of vascular injury. This combination product replaces deficient or dysfunctional clotting factors in affected individuals, thereby promoting hemostasis during bleeding episodes or surgical procedures[1][5][8]. The primary indications are treatment and prevention of bleeding in VWD (all types) and hemophilia A[1][5]. The product is administered intravenously.

Brand names

AlphanateHumate-PWilateBiostate

Other names

antihemophilic factor viii and von Willebrand factorfactor viii / vwf complexantihemophilic factor-vwf